Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 5
R&D Momentum
85/100
Pipeline Velocity
62/100
Trial Completion Rate
76/100
Pipeline Concentration
21/100
Pipeline Freshness
75/100
Strategic Signals
Activity
Last 14 days
Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos
Phase 2 Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
Home Rehabilitation After Acute Pulmonary Embolism
Sensory Phenotyping to Enhance Neuropathic Pain Drug Development (SPENDD): A Randomized, Double-blinded Cross-over Clinical Trial Aimed at Investigating Whether Bedside Quantitative Sensory Testing Can Predict Response to Analgesics.
The Effects of Disulfiram on Visual Acuity in Patients With Retinal Degeneration
A Phase II Study of Steroid Sparing Treatment With Daratumumab and Lenalidomide in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma
Statistical Learning as a Novel Intervention for Cortical Blindness
A Telehealth Advance Care Planning Intervention for Older Patients With Myeloid Malignancies: A Pilot Randomized Controlled Trial
An Exercise and COgnitive Rehabilitation Intervention for Older Cancer Survivors (The E-Co Study)
Phase Resolved Functional Lung MRI and Oscillometry for the Observation of Healthy Lung Function
A Clinical Evaluation of the BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber in Subjects With Mild to Moderate Dry Eye Disease
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)